Bridgebio Pharma, Inc.

Overview

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Pharmaceutical Preparation Manufacturing325412

Federal awards